Cost of new drugs could rise under CETA, but it's hard to predict by how much
When the Canada-EU trade deal was under negotiation, studies forecast billion-dollar price increases for Canada's health care system when brand-name drug patents are extended. Now the government won't project what the actual cost might be. Why?
from CBC | Health News http://ift.tt/2gJercb
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
0 commentaires:
Enregistrer un commentaire